2/3
07:00 am
tngx
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Tango Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
1/28
05:49 pm
tngx
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]
Medium
Report
DUB Inhibitors Market to Witness Strong Expansion Across 7MM by 2040 Driven by the Launch of Novel Therapeutics | DelveInsight [Yahoo! Finance]
1/9
01:46 pm
tngx
Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
Low
Report
Does Tango Therapeutics' (TNGX) CEO Transition Clarify or Complicate Its Precision Oncology Roadmap? [Yahoo! Finance]
1/8
07:05 pm
tngx
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]
Medium
Report
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor [Yahoo! Finance]
1/8
09:05 am
tngx
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
Medium
Report
Tango Therapeutics Announces CEO Transition: Barbara Weber to Retire, Malte Peters Appointed Successor
1/5
07:19 am
tngx
Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]
Medium
Report
Tango Therapeutics Appoints Sung Lee to Board of Directors [Yahoo! Finance]
1/5
07:00 am
tngx
Tango Therapeutics Appoints Sung Lee to Board of Directors
Medium
Report
Tango Therapeutics Appoints Sung Lee to Board of Directors
12/17
07:00 am
tngx
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tango Therapeutics to Participate in 44th Annual J.P. Morgan Healthcare Conference
12/14
03:16 pm
tngx
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing [Yahoo! Finance]
Low
Report
Is Tango Therapeutics (TNGX) Overvalued After a 200% One-Year Surge? A Fresh Look at Its Pricing [Yahoo! Finance]
12/13
01:10 am
tngx
Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at
Wall Street
Low
Report
Tango Therapeutics (NASDAQ:TNGX) was upgraded by analysts at
Wall Street
12/3
06:05 pm
tngx
Tango Therapeutics (NASDAQ:TNGX) was given a new $15.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) was given a new $15.00 price target on by analysts at Stifel Nicolaus.
11/26
07:15 am
tngx
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/26
07:00 am
tngx
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Tango Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/21
04:24 pm
tngx
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy [Seeking Alpha]
Medium
Report
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy [Seeking Alpha]
11/18
12:20 pm
tngx
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at B. Riley from $8.00 to $14.00. They now have a "buy" rating on the stock.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) had its price target raised by analysts at B. Riley from $8.00 to $14.00. They now have a "buy" rating on the stock.
11/18
09:00 am
tngx
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Low
Report
Tango Therapeutics (NASDAQ:TNGX) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/14
07:08 pm
tngx
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue [Yahoo! Finance]
Low
Report
How Investors May Respond To Tango Therapeutics (TNGX) Posting First Profit on Surging Q3 Revenue [Yahoo! Finance]
11/14
12:00 am
tngx
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price [Yahoo! Finance]
Medium
Report
Tango Therapeutics (TNGX): Evaluating Valuation Following Strong Revenue Growth and Doubling Share Price [Yahoo! Finance]
11/12
07:00 am
tngx
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference
Medium
Report
Tango Therapeutics to Participate in the 2025 Jefferies Global Healthcare Conference